Quick Summary — CAMP scores higher on quality with 6.1/10 vs CBUS's 5.7/10. CAMP trades at $3.98 while CBUS trades at $1.39. Both analyzed daily using SEC EDGAR data across 13 institutional models.
CAMP scores higher with a 6.1/10 quality rating vs CBUS's 5.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $3.98, CAMP trades +90.9% above its Bayesian DCF fair value of $0.36, while CBUS at $1.39 trades +73.6% above its estimate of $0.37. CAMP shows a wider gap between price and intrinsic value.
CAMP earns a Quality of Company score of 6.1/10 compared to CBUS's 5.7/10. The scores are closely matched, indicating similar fundamental quality profiles. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
CAMP carries a SAFE value trap risk (18/100) while CBUS shows LOW risk (33/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.
Both CAMP and CBUS operate in Biotechnology, which has 566 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare CAMP vs CBUS differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.